T cells specific for a polymorphic segment of CD45 induce graft-versus- host disease with predominant pulmonary vasculitis

Journal of Immunology

Volumn 161, Issue 2, 1998, Pages 909-918

  Chen, Wei ^a,d   Chatta, Gurkamal S ^a,e   Rubin, William D ^a   Clark, Joan G ^c   Hackman, Robert C ^b,c   Madtes, David K ^c   Ligitt, Denny H ^b   Kusunoki, Yoichiro ^c   Martin, Paul J ^c   Cheever, Martin A ^a,f  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

^f GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CHIMERA; EFFECTOR CELL; GENETIC POLYMORPHISM; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; IMMUNOREACTIVITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY VEIN; T LYMPHOCYTE ACTIVATION; VASCULITIS;

ANIMALS; ANTIGENS, CD45; CELL COMMUNICATION; CELL LINE; CELL MOVEMENT; CLONE CELLS; EPITOPES, T-LYMPHOCYTE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELLS; INJECTIONS, INTRAVENOUS; LEUKOCYTES, MONONUCLEAR; LIVER; LUNG DISEASES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; POLYMORPHISM, GENETIC; PULMONARY FIBROSIS; SPLEEN; T-LYMPHOCYTE SUBSETS; VASCULITIS;

EID: 0032528413     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. den-Haan, J. M. M., N. E. Sherman, E. Blokland, E. Huczko, F. Koning, J. W. Drijfhout, J. Skipper, J. Shabanowitz, D. F. Hunt, V. E. Engelhard, and E. Goulmy. 1995. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 268:1476.
2. Goulmy, E., P. Voogt, C. van-Els, M. de-Bueger, and J. van-Rood. 1991. The role of minor histocompatibility antigens in GVHD and rejection: a mini-review. Bone Marrow Transplant. 1:49.
3. Sale, G. E. 1996. Does graft-versus-host disease attack epithelial stem cells? Mol. Med. Today 2:114.
4. Ferrara, J. L. 1995. Cytokine inhibitors and graft-versus-host disease. Ann. NY Acad. Sci. 770:227.
5. de-Bueger, M., A. Bakker, J. J. Van-Rood, F. Van-der-Woude, and E. Goulmy. 1992. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J. Immunol. 149:1788.
6. van-der-Harst, D., E. Goulmy, J. H. Falkenburg, Y. M. Kooij-Winkelaar, S. A. van-Luxemburg-Heijs, H. M. Goselink, and A. Brand. 1994. Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood 83:1060.
7. van-Lochem, E., B. de-Gast, and E. Goulmy. 1992. In vitro separation of host specific graft-versus-host and graft-versus-leukemia cytotoxic T cell activities. Bone Marrow Transplant. 10:181.
8. Marijt, W. A., W. F. Veenhof, E. Goulmy, R. Willemze, J. J. van-Rood, and J. H. Falkenburg. 1993. Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact. Blood 82:3778.
9. Seldin, M. F., L. A. D'Hoostelaere, A. D. Steinberg, Y. Saga, and H. C. Morse III. 1987. Allelic variants of Ly-5 in inbred and natural populations of mice. Immunogenetics 26:74.
10. Shen, F. W., J. S. Tung, and E. A. Boyse. 1986. Further definition of the Ly-5 system. Immunogenetics 24:146.
11. Zebedee, S. L., D. Barritt, R. Epstein, and W. C. Raschke. 1991. Analysis of Ly5 chromosome 1 position using allelic differences and recombinant inbred mice. Eur J. Immunogen. 18:155.
12. Raschke, W. C., M. Hendricks, and C. M. Chen. 1995. Genetic basis of antigenic differences between three alleles of Ly5 (CD45) in mice. Immunogenetics 41: 144.
13. Erbe, J. G., K. A. Green, K. M. Crassi, H. C. Morse III, and W. R. Green. 1992. Cytolytic T lymphocytes specific for tumors and infected cells from mice with a retrovirus-induced immunodeficiency syndrome. J. Virol. 66:3251.
14. Fefer, A., J. L. McCoy, and J. P. Glynn. 1967. Antigenicity of a virus-induced murine sarcoma (Moloney). Cancer Res. 27:962.
15. bcr-abl protein. Proc. Natl. Acad. Sci. USA 89:1468.
16. Martin, P. J. 1993. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J. Exp. Med. 178:703.
17. Forsyth, K. D., K. Y. Chua, V. Talbot, and W. R. Thomas. 1993. Expression of the leukocyte common antigen CD45 by endothelium. J. Immunol. 150:3471.
18. Rotzschke, O., K. Falk, H. J. Wallny, S. Faath, and H. G. Rammensee. 1990. Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. Science 249:283.
19. Wallny, H. J., and H. G. Rammensee. 1990. Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature 343:275.
20. Speiser, D. E., T. Zurcher, H. Ramseier, H. Hengartner, P. Staeheli, O. Haller, and R. M. Zinkemagel. 1990. Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen. Proc. Natl. Acad. Sci. USA 87:2021.
21. 2-microglobulin by cytotoxic T lymphocytes. Nature 319:502.
22. Madtes, D. K., and S. W. Crawford. 1997. Lung injuries associated with graft-versus-host reactions. In Graft vs Host Disease. J. L. M. Ferrara, H. J. Deeg, and S. J. Burakoff, eds. Marcel Dekker, New York, pp. 425-446.
23. Sale, G. E., H. M. Shulman, and R. C. Hackman. 1994. Pathology of bone marrow transplantation. In Bone Marrow Transplantation. S. J. Forman, K. G. Blume, and E. D. Thomas, eds. Blackwell, Boston, pp. 189-203.
24. Workman, D. L., and J. Clancy, Jr. 1994. Interstitial pneumonitis and lymphocytic bronchiolitis/bronchitis as a direct result of acute lethal graft-versus-host disease duplicate the histopathology of lung allograft rejection. Transplantation 58:207.
25. Wojno, K. J., G. B. Vogelsang, W. E. Beschorner, and G. W. Santos. 1994. Pulmonary hemorrhage as a cause of death in allogeneic bone marrow recipients with severe acute graft-versus-host disease. Transplantation 57:88.
26. Schwarer, A. P., J. M. Hughes, B. Trotman-Dickenson, T. Krausz, and J. M. Goldman. 1992. A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation. Transplantation 54: 1002.
27. Crawford, S. W., and J. G. Clark. 1993. Bronchiolitis associated with bone marrow transplantation. Clin. Chest Med. 14:741.
28. Curtis, D. J., A. Smale, F. Thien, A. P. Schwarer, and J. Szer. 1995. Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant. 16:169.
29. Schultz, K. R., G. J. Green, D. Wensley, M. A. Sargent, J. F. Magee, J. J. Spinelli, S. Pritchard, J. H. Davis, P. C. Rogers, K. W. Chan, and G. L. Phillips. 1994. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood 84:3212.
30. + allogeneic vascular endothelium: identification of accessory interactions. Transplantation 56:128.
31. + memory T lymphocytes induces expression of endothelial leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1 on the surface of vascular endothelial cells. Eur. J. Immunol. 21:2915.
32. Lechler, R., G. Aichinger, and L. Lightstone. 1996. The endogenous pathway of MHC class IJ antigen presentation. Immunol. Rev. 151:51.
33. Sullivan, K. M., P. Weiden, R. Storb, R. P. Witherspoon, A. Fefer, L. Fisher, C. D. Buckner, C. Anasetti, F. R. Appelbaum, C. Badger, P. Beatty, W. Bensinger, et al. 1989. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 73:1720.
34. Jones, R. J., R. F. Ambinder, S. Piantadosi, and G. W. Santos. 1991. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 77:649.
35. Porter, D. L., M. S. Roth, C. McGarigle, J. L. Ferrara, and J. H. Antin. 1994. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N. Engl. J. Med. 330:100.
36. Krenger, W., and J. L. Ferrara. 1996. Graft-versus-host disease and the Th1/Th2 paradigm. Immunol. Res. 15:50.
37. Fowler, D. H., K. Kurasawa, R. Smith, M. A. Eckhaus, and R. E. Gress. 1994. Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood 84:3540.
38. + Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. J. Immunol 157:4811.